NSE BSE
vista pharmaceuticals ltd. stock

VISTA PHARMACEUTICALS LTD. Share Price

- - (%)
Sector: -

524711

VISTAPH

img img img img
No Data Available

VISTA PHARMACEUTICALS LTD. Share Price Update


As of the latest trading session, VISTA PHARMACEUTICALS LTD. share price is currently at 14.5, which is up by 0.68 from its previous closing. Today, the stock has fluctuated between 14.45 and 14.45. Over the past year, VISTA PHARMACEUTICALS LTD. has achieved a return of 54.47 %. In the last month alone, the return has been -1.35 %.

VISTA PHARMACEUTICALS LTD. Performance

Day Range

Low14.45 High14.45
13.98

52 Week Range

Low 7.95 High 19.70
13.98

Open Price

14.45

Prev. Close

13.81

Volume (Shares)

7707.00

Total traded value

1.07

Upper Circuit

14.68

Lower Circuit

13.30

Note: The current prices & values are delayed, Login to your account for live updates.

VISTA PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 56.10
PE Ratio (TTM) 0.00
Book Value / Share 9.66
Beta 0.55
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.63

VISTA PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 1.70
Operating Expense 3.92
Net Profit -1.63
Net Profit Margin (%) -95.88
Earnings Per Share (EPS) -0.33
EBITDA -1.72
Effective Tax Rate (%) 25.90
Particulars SEP 2023 (Values in Cr)
Revenue 3.47
Operating Expense 5.14
Net Profit -2.02
Net Profit Margin (%) -58.21
Earnings Per Share (EPS) -0.46
EBITDA -1.09
Effective Tax Rate (%) -27.04
Particulars JUN 2023 (Values in Cr)
Revenue 1.98
Operating Expense 3.41
Net Profit -0.95
Net Profit Margin (%) -47.97
Earnings Per Share (EPS) -0.23
EBITDA -0.78
Effective Tax Rate (%) 25.58
Particulars MAR 2023 (Values in Cr)
Revenue 1.00
Operating Expense 5.08
Net Profit -3.71
Net Profit Margin (%) -371.00
Earnings Per Share (EPS) -1.00
EBITDA -3.20
Effective Tax Rate (%) -1.08
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.89
Net Profit -0.96
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.27
EBITDA -0.33
Effective Tax Rate (%) -7.86
Particulars MAR 2023 (Values in Cr)
Revenue 1.00
Operating Expense 7.28
Net Profit -5.66
Net Profit Margin (%) -566.00
Earnings Per Share (EPS) -1.54
EBITDA -4.05
Effective Tax Rate (%) 3.57
Particulars MAR 2022 (Values in Cr)
Revenue 0.39
Operating Expense 3.12
Net Profit -0.83
Net Profit Margin (%) -212.82
Earnings Per Share (EPS) -0.24
EBITDA -1.04
Effective Tax Rate (%) 67.57
Particulars MAR 2021 (Values in Cr)
Revenue 1.27
Operating Expense 5.27
Net Profit -2.01
Net Profit Margin (%) -158.26
Earnings Per Share (EPS) -0.54
EBITDA -1.52
Effective Tax Rate (%) 47.24
Particulars MAR 2020 (Values in Cr)
Revenue 22.76
Operating Expense 30.43
Net Profit -3.68
Net Profit Margin (%) -16.16
Earnings Per Share (EPS) -1.22
EBITDA -1.04
Effective Tax Rate (%) 6.59
Particulars MAR 2019 (Values in Cr)
Revenue 31.07
Operating Expense 32.87
Net Profit 0.94
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 0.76
EBITDA 4.18
Effective Tax Rate (%) 18.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin -392.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.34
EBITDA Margin -282.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin -120.47
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.76
ROE % -11.25
ROCE % -5.21
Total Debt to Total Equity 0.41
EBITDA Margin -4.61
Particulars MAR 2019 (Values in Cr)
Book Value / Share 10.97
ROE % 2.78
ROCE % 6.27
Total Debt to Total Equity 0.33
EBITDA Margin 13.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 56.02
Total Liabilities 56.02
Total Equity 36.70
Share Outstanding 37556639
Price to Book Ratio 1.03
Return on Assets (%) -10.10
Return on Capital (%) -12.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 55.58
Total Liabilities 55.58
Total Equity 35.45
Share Outstanding 36793907
Price to Book Ratio 0.96
Return on Assets (%) -1.59
Return on Capital (%) -1.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 50.85
Total Liabilities 50.85
Total Equity 32.84
Share Outstanding 36793907
Price to Book Ratio 1.01
Return on Assets (%) -3.94
Return on Capital (%) -4.61
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 51.12
Total Liabilities 51.12
Total Equity 29.64
Share Outstanding 30365337
Price to Book Ratio 0.54
Return on Assets (%) -7.19
Return on Capital (%) -8.15
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.86
Total Assets 52.75
Total Liabilities 52.75
Total Equity 35.80
Share Outstanding 30365337
Price to Book Ratio 1.84
Return on Assets (%) 1.78
Return on Capital (%) 2
Particulars MAR 2023 (Values in Cr)
Net Income -5.87
Cash from Operations -2.76
Cash from Investing -1.27
Cash from Financing 3.11
Net change in Cash 0.13
Free Cash Flow -1.49
Particulars MAR 2022 (Values in Cr)
Net Income -2.61
Cash from Operations -0.99
Cash from Investing -0.01
Cash from Financing 0.93
Net change in Cash -0.06
Free Cash Flow -0.97
Particulars MAR 2021 (Values in Cr)
Net Income -3.68
Cash from Operations -6.74
Cash from Investing -0.29
Cash from Financing 6.96
Net change in Cash -0.08
Free Cash Flow -6.44
Particulars MAR 2020 (Values in Cr)
Net Income -3.93
Cash from Operations 0.80
Cash from Investing -1.72
Cash from Financing 0.28
Net change in Cash -0.64
Free Cash Flow 1.04
Particulars MAR 2019 (Values in Cr)
Net Income 1.14
Cash from Operations 3.67
Cash from Investing -5.64
Cash from Financing 1.43
Net change in Cash -0.92
Free Cash Flow 6.99
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
VISTA PHARMACEUTICALS LTD. 13.81 0.00 1.42 53.61 7.95 / 19.70
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 14.00
  • 26 Days 14.00
  • 10 Days 14.00
  • 50 Days 13.70
  • 12 Days 14.00
  • 100 Days 14.30
  • 20 Days 14.00
  • 200 Days 10.00
13.90
PIVOT
First Resistance 14.32
Second Resistance 14.82
Third Resistance 15.24
First Support 13.40
Second Support 12.98
Third Support 12.48
RSI 53.39
MACD 0.05
Commodity Channel Index (CCI) -16.68
ADX 33.17
Williams % R -72.43

Over 1 Month

down

-1.35

Over 3 Months

down

-11.18

Over 6 Months

down

-25.75

Over 1 Year

down

54.47

Over 3 Years

down

4.64

Over 5 Years

down

-3.78

VISTA PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VISTA PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
64.52
Promoter Holdings
35.44
FII
0.0
DII
0.03
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Vista Pharmaceuticals Inc Shareholding of Promoter and Promoter Group 6579620.0 17.88
Umakanth Katta Public Shareholding 5000000.0 13.59
Dhananjaya Alli Shareholding of Promoter and Promoter Group 2887424.0 7.85
Suresh Gadalay Public Shareholding 2855604.0 7.76
Kamal Gadalay Public Shareholding 1801169.0 4.9
Vasant V Alli Shareholding of Promoter and Promoter Group 1601478.0 4.35
Keshava Murthy Shiva Shankar Public Shareholding 1255158.0 3.41
Andhra Pradesh Industrial Development Corporation Limited Shareholding of Promoter and Promoter Group 750000.0 2.04
Rajendar Balakrishna Public Shareholding 700000.0 1.9
Padmavathi Alli Shareholding of Promoter and Promoter Group 463666.0 1.26
Vamsi V Alli Shareholding of Promoter and Promoter Group 416666.0 1.13
Roshni Alli Shareholding of Promoter and Promoter Group 341333.0 0.93

VISTA PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2015-06-25 10.0 2.0 2015-06-26

Learn More About Stocks

About VISTA PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VISTA PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vista Pharmaceuticals Ltd?

Answer Field

The share price of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 14.5.

What is the Market Cap of Vista Pharmaceuticals Ltd?

Answer Field

The market cap of Vista Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 56.10 Cr. as of now.

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.70 and ₹ 7.95.

How to Buy Vista Pharmaceuticals Ltd share?

Answer Field

You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vista Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 54.47%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader